Search clinical trials for: Osimertinib
Total 243 results
-
AstraZenecaActive, not recruitingNon Small Cell Lung Cancer (Stage III)United States, Spain, Taiwan, Thailand, Vietnam, Turkey, Korea, Republic of, Brazil, Hungary, India, Japan, Mexico, Peru, Russian Federation, China, Malaysia, Argentina
-
Li ZhangHubei Cancer HospitalNot yet recruitingStage IV Non-small Cell Lung CancerChina
-
Qingdao Central HospitalRecruiting
-
Wuhan Union Hospital, ChinaNot yet recruitingNon Small Cell Lung Cancer
-
Vestre Viken Hospital TrustActive, not recruitingLung CancerDenmark, Sweden, Lithuania, Norway
-
AstraZenecaTerminated
-
Istituto Oncologico Veneto IRCCSActive, not recruitingEGF-R Positive Non-Small Cell Lung CancerItaly
-
Shanghai JMT-Bio Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingLocally Advanced or Metastatic Non-Small Cell Lung Cancer | EGFR Exon20 Insertion Mutations
-
Qingdao Central HospitalRecruiting
-
AstraZenecaCompletedT790M Positive NSCLC PatientsChina
-
Sun Yat-sen UniversityUnknownNon-small Cell Lung CancerChina
-
Suzhou Genhouse Bio Co., Ltd.RecruitingNon-Small Cell Lung Cancer With EGFR MutationChina
-
Blueprint Medicines CorporationActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | EGF-R Positive Non-Small Cell Lung... and other conditionsUnited States, Canada, Taiwan, Korea, Republic of, Singapore, Japan, United Kingdom, France, Netherlands, Spain
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerUnited States, Argentina, India, Taiwan, Thailand, Vietnam
-
Samsung Medical CenterWithdrawnLung CancerKorea, Republic of
-
Duke UniversityCompletedA Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR MutationsNon Small Cell Lung CancerUnited States
-
Agency for Healthcare Research and Quality (AHRQ)Marshfield Clinic Research FoundationUnknownAtrial Fibrillation | Pulmonary Embolism | Deep Venous Thrombosis | Heart Valve ReplacementUnited States
-
Molecular Partners AGTerminatedEGFR-mutated NSCLC (Disorder)United States
-
Sichuan Baili Pharmaceutical Co., Ltd.RecruitingNon-small Cell Lung CancerChina
-
Samsung Medical CenterAstraZenecaCompletedEfficacy and Safety of 80mg Osimertinib in Patients With Non-small Cell Lung Cancer(NSCLC) (BLOSSOM)Non-small Cell Lung Cancer (NSCLC)Korea, Republic of
-
AstraZenecaQuintiles, Inc.CompletedSolid TumoursFrance, Korea, Republic of, Spain
-
National Cancer Centre, SingaporeTaiho Pharmaceutical Co., Ltd.Recruiting
-
Seoul National University HospitalAstraZeneca; Korean Cancer Study GroupCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of
-
Jiesi Yingda Pharmaceutical Technology (Suzhou)...RecruitingAdvanced Non-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung CancerChina
-
Sun Yat-sen UniversityRecruiting
-
Mark VincentAstraZenecaRecruitingNon-Small Cell Lung CancerCanada
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingNonsmall-cell Lung CancerChina
-
AstraZenecaCompletedNon-small Cell Lung CancerSweden
-
Tianjin Medical University Cancer Institute and...Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Unknown
-
LianBio LLCRecruiting
-
Tianjin Medical University Cancer Institute and...RecruitingNon-small Cell Lung Cancer | EGFR Activating Mutation | EGFR-TKI Resistant Mutation | Cell Cycle DeregulationChina
-
AstraZenecaHutchison MediPharmaRecruitingCarcinomaDenmark, Spain, United States, Taiwan, Vietnam, Canada, Korea, Republic of, Brazil, India, Japan, Italy, Puerto Rico, France, Chile
-
Nantes University HospitalAstraZenecaActive, not recruitingNon-small Cell Lung CancerFrance
-
Shanghai JMT-Bio Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownLocally Advanced or Metastatic Non-Small Cell Lung CancerChina
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.RecruitingEGFR Positive Non-small Cell Lung CancerChina
-
M.D. Anderson Cancer CenterWithdrawn
-
First Affiliated Hospital of Zhejiang UniversityTerminatedNon Small Cell Lung CancerChina
-
AstraZenecaActive, not recruitingAnticancer TreatmentUnited States, France, Germany, Spain, Sweden, United Kingdom, Canada, Italy, Korea, Republic of, Hungary, Japan, Russian Federation, China, Taiwan, Hong Kong, Netherlands, Australia, Mexico
-
AstraZenecaParexelActive, not recruitingNon-small Cell Lung CancerItaly, Spain, United States, China, Germany, Israel
-
Samsung Medical CenterRecruitingLung AdenocarcinomaKorea, Republic of
-
Revolution Medicines, Inc.SanofiCompletedSolid TumorUnited States, Korea, Republic of
-
AstraZenecaRecruitingStage II-IIIB Non-small Cell Lung CarcinomaSpain, Korea, Republic of, Philippines, Italy, United States, Malaysia, Taiwan, Thailand, Hong Kong, United Kingdom, Singapore
-
National Cancer Institute (NCI)CompletedLung Neoplasms | Lung AdenocarcinomaUnited States
-
Genprex, Inc.RecruitingCarcinoma, Non-Small Cell LungUnited States
-
University of Colorado, DenverCancer League of ColoradoCompletedNon Small Cell Lung Cancer | CNS ProgressionUnited States
-
AstraZenecaRecruitingCarcinoma, Non-Small-Cell LungUnited States, China, Israel, United Kingdom, Korea, Republic of, Canada, Italy, Poland, Spain, Belgium, Netherlands, Japan, Germany, Brazil, France, Turkey, Russian Federation, Greece, Australia, Puerto Rico
-
University Hospital, MontpellierCompleted
-
AstraZenecaDaiichi SankyoNot yet recruitingNon-small Cell Lung CancerChina, Taiwan, Korea, Republic of, Australia
-
Hutchison Medipharma LimitedRecruitingNon-small Cell Lung CancerChina